Welcome!

A word from Dr. Panagopoulos: “I am delighted to offer compassionate evidence-based care in Psychiatry for residents of New York, Texas and California. Having trained at prestigious US medical schools and having worked at multiple hospitals over telemedicine for several years, I now strive to provide excellent care for any type of mental health problem in a profoundly humane and respectful manner at the comfort of your own home.”

Responsive

We strive to be responsive to the needs of our patients!

Quality

We aspire to provide excellent, evidenced-based clinical care

Support

We respect the needs and unique nature of each individual person

Meet Dr. Panagopoulos

Dr. Panagopoulos is a Yale-trained dual board-certified Psychiatrist currently serving as the Director of Tranquil Days Behavioral Health. He holds certifications by the American Board of Psychiatry and Neurology in both Adult and Addiction Psychiatry. He offers both medication management services (prescribing medication for behavioral health) as well as psychotherapy services (counseling). His Addiction Psychiatry subspecialty extends his psychiatric skill-set to serve the needs of his patients in multiple domains but also to assist the community in very frequently encountered problems such as tobacco and alcohol use problems. Dr. Panagopoulos was born and raised in Athens, Greece. He completed medical school at the University of Patras Medical School in 2006 with a honorary distinction for being among the 5 highest-ranking medical students of his class. He completed his residency training as an Adult Psychiatrist at Washington University School of Medicine in St. Louis, MO, USA in 2012. He then expanded his training by completing the Addiction Psychiatry fellowship of Yale University at New Haven, CT, USA. He was formerly employed at the St. Louis Veterans Administration Healthcare System as a Staff Psychiatrist for almost 2 years taking care of Veterans with addiction and multiple other psychiatric problems. During his tenure at the VA, he served as a Clinical Instructor at Washington University School Of Medicine, St. Louis, MO, USA, and was heavily involved in teaching residents and medical students about addiction and psychiatry. Dr. Panagopoulos has expertise in several different psychotherapeutic techniques including Cognitive Behavioral Therapy, Group Therapy and Motivational Interviewing. He has an enthusiastic interest and significant related experience in the application of modern technologies in the daily clinical practice of psychiatry through the practice of telemedicine, as evidenced by his service at multiple Dignity Health Hospitals, at El Camino Hospital at Mountain View & Los Gatos, as well as Stanford Health Care Tri-Valley.
Vassilis N. Panagopoulos, MD

Vassilis N. Panagopoulos, MD

Diplomate of the American Board of Psychiatry and Neurology

Educational Material

Holiday Sadness

Is depression really common during the Christmas holiday? The answer is that, yes, it’s common. There are multiple reasons for this. Below we will analyze a few of these reasons. The expectation of happiness underlines one’s current state of sadness The general expectation in most Western cultures is that during the holiday season one is supposed to be celebrating and feel happy. But those people who don’t feel happy no matter what the...

Major depressive disorder

How frequent is depression? Major depressive disorder (oftentimes referred to as “depression” by the general public) is the most common major psychiatric disorder. Approximately 15% of the general population is affected by this illness at some point during their lifetime. Depression is almost twice as common in women as it is in men. Symptoms and course Major depressive disorder is characterized by the occurrence of episodes of clinical depression which are called...

Naltrexone for opioid addiction

What is naltrexone? Naltrexone is a medication approved for the treatment of opioid use disorder (opioid dependence). It blocks the μ (mu) opioid receptor in the brain, displacing most other opioids and rendering them basically inactive in that regard. If a person under treatment with naltrexone, takes an opioid (e.g. heroin, oxycodone, hydrocodone etc), the opioid ingestedcannot activate the μ opioid receptors and thus exert its actions to the body...